Literature DB >> 24568862

Differential role of molten globule and protein folding in distinguishing unique features of botulinum neurotoxin.

Raj Kumar1, Roshan V Kukreja1, Shuowei Cai1, Bal R Singh2.   

Abstract

Botulinum neurotoxins (BoNTs) are proteins of great interest not only because of their extreme toxicity but also paradoxically for their therapeutic applications. All the known serotypes (A-G) have varying degrees of longevity and potency inside the neuronal cell. Differential chemical modifications such as phosphorylation and ubiquitination have been suggested as possible mechanisms for their longevity, but the molecular basis of the longevity remains unclear. Since the endopeptidase domain (light chain; LC) of toxin apparently survives inside the neuronal cells for months, it is important to examine the structural features of this domain to understand its resistance to intracellular degradation. Published crystal structures (both botulinum neurotoxins and endopeptidase domain) have not provided adequate explanation for the intracellular longevity of the domain. Structural features obtained from spectroscopic analysis of LCA and LCB were similar, and a PRIME (PReImminent Molten Globule Enzyme) conformation appears to be responsible for their optimal enzymatic activity at 37°C. LCE, on the other hand, was although optimally active at 37°C, but its active conformation differed from the PRIME conformation of LCA and LCB. This study establishes and confirms our earlier finding that an optimally active conformation of these proteins in the form of PRIME exists for the most poisonous poison, botulinum neurotoxin. There are substantial variations in the structural and functional characteristics of these active molten globule related structures among the three BoNT endopeptidases examined. These differential conformations of LCs are important in understanding the fundamental structural features of proteins, and their possible connection to intracellular longevity could provide significant clues for devising new countermeasures and effective therapeutics.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Enzyme catalysis; Fluorescence; Protein conformation; Protein denaturation; Protein folding

Mesh:

Substances:

Year:  2014        PMID: 24568862     DOI: 10.1016/j.bbapap.2014.02.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Systematic discovery of molecular probes targeting multiple non-orthosteric and spatially distinct sites in the botulinum neurotoxin subtype A (BoNT/A).

Authors:  Saedeh Dadgar; Wely B Floriano
Journal:  Mol Cell Probes       Date:  2015-03-04       Impact factor: 2.365

2.  High Yield Preparation of Functionally Active Catalytic-Translocation Domain Module of Botulinum Neurotoxin Type A That Exhibits Uniquely Different Enzyme Kinetics.

Authors:  Harkiranpreet Kaur Dhaliwal; Nagarajan Thiruvanakarasu; Raj Kumar; Kruti Patel; Ghuncha Ambrin; Shouwei Cai; Bal Ram Singh
Journal:  Protein J       Date:  2017-12       Impact factor: 2.371

3.  Antidotal treatment of botulism in rats by continuous infusion with 3,4-diaminopyridine.

Authors:  James B Machamer; Edwin J Vazquez-Cintron; Sean W O'Brien; Kyle E Kelly; Amber C Altvater; Kathleen T Pagarigan; Parker B Dubee; Celinia A Ondeck; Patrick M McNutt
Journal:  Mol Med       Date:  2022-06-03       Impact factor: 6.376

4.  Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.

Authors:  Kruti B Patel; Shuowei Cai; Michael Adler; Brajendra K Singh; Virinder S Parmar; Bal Ram Singh
Journal:  Appl Environ Microbiol       Date:  2018-11-30       Impact factor: 4.792

5.  Optimization of SNAP-25 and VAMP-2 Cleavage by Botulinum Neurotoxin Serotypes A-F Employing Taguchi Design-of-Experiments.

Authors:  Laura von Berg; Daniel Stern; Jasmin Weisemann; Andreas Rummel; Martin Bernhard Dorner; Brigitte Gertrud Dorner
Journal:  Toxins (Basel)       Date:  2019-10-11       Impact factor: 4.546

6.  A novel role of C-terminus in introducing a functionally flexible structure critical for the biological activity of botulinum neurotoxin.

Authors:  Thomas M Feltrup; Kruti Patel; Raj Kumar; Shuowei Cai; Bal Ram Singh
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

7.  Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function.

Authors:  Jacqueline M Tremblay; Edwin Vazquez-Cintron; Kwok-Ho Lam; Jean Mukherjee; Daniela Bedenice; Celinia A Ondeck; Matthieu T Conroy; Skylar M L Bodt; Brittany M Winner; Robert P Webb; Konstantin Ichtchenko; Rongsheng Jin; Patrick M McNutt; Charles B Shoemaker
Journal:  Toxins (Basel)       Date:  2020-09-24       Impact factor: 5.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.